| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.002 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |